Login / Signup

A myelodysplastic neoplasm with del(5q) treated with luspatercept uncovers unexplored mechanisms of action for the drug.

Iraklis PatsialosChristina-Nefeli KontandreopoulouDimitra VlachopoulouChristos StafylidisStavroula SyriopoulouFani KalalaAmalia AnastasopoulouMarina MantzouraniPanagiotis T Diamantopoulos
Published in: British journal of haematology (2024)
Keyphrases
  • acute myeloid leukemia
  • bone marrow
  • low grade
  • adverse drug
  • drug induced